Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	741.17	675.04	482.38	401.86	365.98	353.87
Revenue Growth (YoY)	17.92%	39.94%	20.04%	9.80%	3.42%	15.46%
Cost of Revenue	13.39	10.88	6.48	5.39	5.28	5.58
Gross Profit	727.78	664.16	475.89	396.47	360.7	348.29
Selling, General & Admin	401.86	280.32	184.26	152.85	122.36	105.33
Research & Development	260.35	246.89	184.35	130.99	113.86	114.76
Operating Expenses	662.21	527.21	368.61	283.84	236.22	220.09
Operating Income	65.57	136.95	107.28	112.63	124.48	128.2
Interest & Investment Income	22.94	24.54	17.28	3.56	0.53	3.4
Legal Settlements	-	-	-	-14	-	-
Pretax Income	88.51	161.49	124.56	116.19	125.01	131.6
Income Tax Expense	-17.6	20.28	18.42	14.77	12.49	25.59
Net Income	106.11	141.21	106.14	101.42	112.51	106.01
Preferred Dividends & Other Adjustments	1.45	1.48	0.64	0.13	-	-
Net Income to Common	104.66	139.73	105.5	101.29	112.51	106.01
Net Income Growth	-25.18%	33.04%	4.66%	-9.86%	6.13%	12.56%
Shares Outstanding (Basic)	104	103	104	107	116	115
Shares Outstanding (Diluted)	120	113	112	116	126	124
Shares Change (YoY)	7.55%	1.55%	-3.64%	-7.94%	1.42%	1.33%
EPS (Basic)	1.01	1.35	1.02	0.95	0.97	0.92
EPS (Diluted)	0.87	1.23	0.94	0.87	0.89	0.85
EPS Growth	-30.72%	30.85%	8.05%	-2.25%	4.71%	10.39%
Free Cash Flow	163.1	195.9	126.9	119.91	167.42	150.73
Free Cash Flow Per Share	1.36	1.73	1.14	1.03	1.33	1.21
Gross Margin	98.19%	98.39%	98.66%	98.66%	98.56%	98.42%
Operating Margin	8.85%	20.29%	22.24%	28.03%	34.01%	36.23%
Profit Margin	14.12%	20.70%	21.87%	25.20%	30.74%	29.96%
Free Cash Flow Margin	22.00%	29.02%	26.31%	29.84%	45.75%	42.59%
EBITDA	66.71	137.75	108.32	113.89	125.96	128.73
EBITDA Margin	9.00%	20.41%	22.46%	28.34%	34.42%	36.38%
D&A For EBITDA	1.14	0.8	1.04	1.26	1.48	0.53
EBIT	65.57	136.95	107.28	112.63	124.48	128.2
EBIT Margin	8.85%	20.29%	22.24%	28.03%	34.01%	36.23%
Effective Tax Rate	-	12.56%	14.79%	12.71%	9.99%	19.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.